Purchase Order 75N95020P00411
- Not listed
- This is a $23,230 firm fixed-price purchase order contract awarded to Miltenyi Biotec, Inc., a global biotechnology company, by the National Institute on Aging, a civilian federal agency. The contract delivers specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation, including flow cytometers, cell sorters, tissue dissociators, automated cell separation systems, and associated consumables. Miltenyi Biotec has an...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Nursing Research (NINR), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. for the maintenance of a MILTENYI MACSQUANT 10 ANALYZER. The contract has a ceiling value of $89,344.06 and a period of performance through January 14, 2026. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies,...
- This $6,929.75 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized instruments, reagents, and services for biomedical research and cell therapy development. The contract does not have a set-aside designation. Miltenyi Biotec is delivering a range of products and services to support NIAID's research programs, particularly in areas such as cancer,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract is for an annual service agreement for MACS analyzers, with a ceiling value of $35,861 and a period of performance ending on February 28, 2021. This is a sole-source award, as Miltenyi Biotec is the only responsible source for the required services....
- This is a $17,976 firm fixed price purchase order awarded to Miltenyi Biotec, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) for laboratory equipment and supplies. The contract is not set aside. Miltenyi Biotec is a global biotechnology company that specializes in cell separation, analysis, and processing technologies. Under this contract, the company will provide a variety of products and services to support biomedical...
- This is a $4,250 firm-fixed-price purchase order contract between the National Institute of Allergy and Infectious Diseases (NIAID) and Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is not set aside and supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Miltenyi Biotec has extensive experience as a prime contractor for numerous...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract, valued at $13,995.00, is for other functions maintenance agreement services. Miltenyi Biotec provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation....
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This federal contract award is for a renewal maintenance agreement on a MACSQuant analyzer instrument, provided by Miltenyi Biotec, Inc. to the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The firm-fixed-price purchase order has a ceiling value of $22,224.00 and an ultimate completion date of March 2, 2023. Miltenyi Biotec is a global biotechnology company that regularly provides specialized laboratory equipment, reagents, and...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of a cell dissociator and cell separator. The award, valued at $58,517.50, was made without a set-aside designation and has an ultimate completion date of September 30, 2017. Miltenyi Biotec is a well-established federal contractor,...
This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency, to Miltenyi Biotec, Inc. for a maintenance agreement. The contract has a ceiling value of $91,800.00 and a period of performance ending on August 10, 2024. The contract does not have a set-aside designation. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. Under this contract, the company will likely deliver and maintain its products, such as flow cytometers, cell sorters, tissue dissociators, and automated cell separation systems, to support NIA's research programs, particularly in areas like cancer, immunology, and infectious diseases. Additionally, Miltenyi Biotec holds a $2.3 million indefinite delivery contract (IDC) with the NIH Clinical Center, awarded in June 2023, to supply proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027. This sole-source contract ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation to support the agency's cell processing and manufacturing capabilities for investigational cell therapy products used in clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Exercise an Option | $23.0k | 7/7/23 | |
| P00004 | Exercise an Option | $23.0k | 6/24/22 | |
| P00003 | Supplemental Agreement for work within scope | $0 | 6/14/22 | |
| P00002 | Supplemental Agreement for work within scope | $0 | 11/17/21 | |
| P00001 | Exercise an Option | $23.0k | 6/23/21 |